Helmut Baumgartner
Institution:
Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Germany
since 2007 – Director, Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Germany
since 2007 – Full Professor (Cardiology/Adult Congenital Heart Disease), University of Muenster, Germany
Previous Appointments
1993 – 2007 Staff cardiologist, Dept. of Cardiology, Medical University – Vienna General Hospital
1993 – 2007 Professor of Medicine / Cardiology, Medical University of Vienna
1993 – 2007 Director, Adult Congenital Heart Disease and Acquired Valvular Heart Disease Program, Medical University of Vienna
1993 – 2007 Director, Research Program on Adult Congenital Heart Disease and Acquired Valvular Heart Disease, Medical University of Vienna
1993 – 2007 Director, In-Vitro Echocardiography Research Laboratory
1993 – 2001 Director, Echocardiography Laboratory, Dept. of Cardiology, Medical University of Vienna
1992 – 1993 Staff cardiologist and Director, Echocardiography Laboratory, 2nd Department of Internal Medicine / Cardiology, Krankenhaus der Barmherzigen Schwestern, Linz, Austria
Postgraduate Training
1981 – 1983 Internship, Krankenhaus der Barmherzigen Schwestern , Linz and St. Pölten General Hospital, Austria
1994 – 1989 Residency/Fellowship, Internal Medicine; 1st and 2nd Dept. of Internal Medicine, Krankenhaus der Barmherzigen Schwestern, Linz, Austria
1989 – 1990 Research Fellowship, Division of Cardiology, Cedars-Sinai Medical Center, University of California at Los Angeles, Los Angeles, USA
1990 – 1991 Clinical Fellowship in Cardiology; 2nd Dept. of Internal Medicine / Cardiology, Krankenhaus der Barmherzigen Schwestern, Linz, Austria
Research Activities
Clinical and basic research in the area of valvular heart disease and congenital heart disease
Clinical and experimental research in echocardiography
Catheter intervention in congenital and acquired valvular heart disease Myocardial viability
More than 250 publications, of these more than 150 papers in peer-reviewed journals
Medical Societies / Fellowships / Journals (selected)
Austrian Society of Cardiology: Chairman of the working group on adult congenital heart disease; President of the Society 2005-2007
European Society of Cardiology: Board member 2006-2008; Nucleus member of the working group on grown-up congenital heart disease, co-chairman 2004-2006, chairman 2006–2008, past-chairman 2008-2010, Chairman, TF Practice guidelines on the management of grown-up congenital heart disease, Task forces and committees (Practice guidelines on the management of valvular heart disease, Education committee, Accreditation committee), Clinical Practice Guidelines Committee (2010-2014),Congress Programme Committee (2010-2014)
Elena Biagini
Institution:
Department of Cardiology at the S. Orsola-Malpighi Hospital, University of Bologna, Italy
since 2007 – Department of Cardiology at the S. Orsola-Malpighi Hospital, University of Bologna, Italy
Previous Appointments
1998 – 2003 Staff cardiologist, Institute of Cardiology, Bologna University,
Bologna, Italy
1999 Royal Brompton Hospital in London, UK
2000 Experience in outpatient medical visit (Heart failure and hypertrophic
cardiomyopathy; cardiorespiratory exercise bike tests; treadmill tests;
implant of temporal and definitive pacemakers; haemodynamic laboratory: experience in coronary angiography and coronary PTCA)
2001 – 2002 Transthoracic echocardiography; transesophageal echocardiography; pediatric cardiology; intensive care unit.
2003 – 2005 Fellowship at the Thoraxcenter, Erasmus MC, Rotterdam, The
Netherlands
Postgraduates
2005 International Philosophiæ Doctor (PhD) in Cardiology at the Erasmus Medical Center University of Rotterdam, The Netherlands
2004 Philosophiæ Doctor (PhD) at the Cardiology Department of S. Orsola-Malpighi Hospital, University of Bologna, Italy
Research Activities
Clinical-care activity of cardiomyopathies
Medical Societies / Fellowships / Journals (selected)
Member of the Task Force for 2023 ESC Guidelines on “Clinical and genetic aspects of cardiomyopathies”.
Member of the Italian Society of Cardiology
Member of the Nucleus of the Study Group of Cardiomyopathies
and Pericardial Diseases, Italian Society of Cardiology
2017 – 2021 member of the Editorial Committee of the Italian Journal of Cardiology
Young Investigators’ Awards
Italian Society of Cardiology 2002: Finalist in Young Investigators’ awards
European Society of Cardiology 2004: Finalist in Young Investigators’ awards in Clinical Science
European Society of Cardiology 2007: Finalist in Young Investigators’ awards in Clinical Science
Italian society of Cardiology 2007: PhD in Cardiovascular area’ awards
Christoph Binder
Institution:
Medical University of Vienna, Austria
Michael Böhm
Institution:
University Saarland, Homburg/Saar, Germany
1977 – 1984 Medical School; Medical School of Hannover
1984 – 1986 Pharmacology; University of Hamburg
1986 – 1993 Internal Medicine and Cardiology; University of Munich
1993 – 2000 Professor of Cardiology; University of Cologne
2000 Professor of Internal Medicine and Cardiology; University of the Saarland, Homburg/Saar
Scientific Career
1980 – 1983 Head of Department of Internal Medicine, Pulmonology and Critical Care Medicine Thoraxklinik Heidelberg
Speciality certification:
1980 – 1983 Training in pharmacology in the Division of Biochemical Pharmacology at the Medical University of Hannover
1984 Doctoral thesis in the Medical Faculty at the Medical University of Hannover (Dept. Biochemical Pharmacol)
1984 – 1986 Resident of the Division of General Pharmacology at the University Hospital of Eppendorf of the University of Hamburg
1986 – 1993 Resident at the Medizinische Klinik I, Klinikum Großhadern, Department of Internal Medicine and Cardiology, Ludwig-Maximilians-Universität München
1992 Certification of Internal Medicine
1993 Assistant Professor of Cardiology at the Klinik III für Innere Medizin, University of Cologne
1993 Certification of Cardiology
1994 Heisenberg-Programm of the Deutsche Forschungsgemeinschaft (DFG)
1995 – 2000 C3-Professorship for Internal Medicine and Cardiology, Innere Medizin III, University of the Cologne
2000 C4-Professorship and Director for Internal Medicine, Cardiology, Angiology and Intensiv Care Medicine, University of the Saarland, Homburg/Saar
2007 President Elect of the German Cardiac Society
2009 President of the German Cardiac Society
2010 Board member and Chairman of the Scientific Program Committee of the European Society of Cardiology (ESC)
2012 Honorary member and medal of merit of the Hungaria Society of Cardiology
2012 Order and Cross of Merit of the Federal Republic of Germany
Scientific Journals
Chief Editor: Clinical Research in Cardiology
Consulting Editor: Basic Research in Cardiology
Editorial Board: Cardiovascular Research, Cardiovascular Drugs and Therapy, European Heart Journal
Reviewer: Circulation, Circulation Research, Hypertension, Lancet, European Journal of Heart Failure, European Heart Journal and others
Trial Experience
National Coordinator: COMET, CORONA, ONTARGET, TRANSCEND, SENIORS, ESSENTIAL
Executive Board: SHIFTDSMBRECORD
Steering Committee: CORONA, ONTARGET, TRANSCEND, SENIORS, ESSENTIAL, ASTRONAUT
Principal Investigator: OPTILINK, EDIfY
Davide Capodanno
Institution:
University of Catania and Azienda Ospedaliero Universitaria “Policlinico G. Rodolico-S. Marco” in Catania, Italy
Davide Capodanno, MD, PhD, is Full Professor of Cardiology at the University of Catania and Interventional Cardiologist at the Cardiac-Thoracic-Vascular and Transplant Department , Azienda Ospedaliero Universitaria “Policlinico G. Rodolico-S. Marco” in Catania, Italy. He received his MD and PhD from the University of Catania and completed his research training at the University of Florida in Jacksonville, US.
Dr Capodanno has authored 650+ manuscripts published in the peer-reviewed literature, including original articles, reviews and editorials. He has co-authored 5 textbooks of interventional cardiology and 17 textbook chapters. He has delivered 200+ invited lectures in international meetings, including ESC, ACC, EuroPCR, TCT, CIT, TCTAP. Dr Capodanno’s areas of interest and expertise include coronary revascularization, drug-eluting stents, antithrombotic pharmacotherapy, trial design and biostatistics.
He is the Co-Director of the PCR Clinical Research Course and Associate Director of TCT. He is a member of the Working Group on Thrombosis of the ESC and a member of the Educative Solutions Research Group Programme of PCR.
Dr Capodanno serves as Editor-in-Chief of Eurointervention, Section Editor of Thrombosis and Haemostasis and Editorial Consultant of JACC Cardiovascular Interventions and Circulation Cardiovascular Interventions.
Pieter Doevendans
Institution:
Director Netherlands Heart Institute
University Utrecht, Utrecht, The Netherlands
Pieter Doevendans became a cardiologist in Maastricht. In 1993-1994 he had the opportunity to work with Ken Chien at UCSD San Diego where the work on stem cells started. The work was completed in Maastricht and provided the basis for a thesis on the promoter of the atrialMLC2 gene. Upon return in the Netherlands he worked with Christine Mummery and Hans Clevers (Hubrecht Laboratory). In the meantime he remained active as an interventional cardiologist initially in Maastricht, but from 2002 on in Utrecht. Here he was appointed full professor in Cardiology in 2004 and head of the department 2005-2020. The focus is on Cardiac Failure, stem cells and genetics. He was funded by various national and international foundations. Thus far (2021) he published more than 900 peer reviewed papers and 12 books. He is an active member of the European Society of Cardiology. Director of the Netherlands Heart Institute since 2015.
Currently PI of MiniECG NWO, Harvey (NWO) Psider-Heart (ZonMW), Geremy (EU).
Founder of LeadPharma, International Cardio Cooperation; HeartEye
Victoria Delgado
Institution:
University Hospital Germans Trias i Pujol and Centre of Competitive Medicine and Bioimaging in Badalona, Spain
Dr. Victoria Delgado is currently the head of the cardiovascular imaging department of the Heart Institute at the University Hospital Germans Trias i Pujol and scientific director of the Centre of Competitive Medicine and Bioimaging in Badalona, Spain. She graduated in medical school at the University of Barcelona (Spain), accomplished her training in Cardiology at the Hospital Clinic in Barcelona (Spain) and followed a 3-year fellowship at the Leiden University Medical Center (The Netherlands) where she was appointed as cardiologist with expertise on multimodality imaging from 2010 till 2021. She obtained her PhD degree cum laude in 2010 at the Leiden University with the thesis entitled Novel Cardiac Imaging Technologies: Implications in Clinical Decision Making.
She has more than 800 per-reviewed publications, and an H-factor of 90. She has contributed to more than 20 textbooks, including the worldwide recognized landmark book Hurst’s The Heart, 15th edition. She has been co-promotor of 17 PhD students and currently supervises 6 PhD fellows.
She has been Associate Editor of the Journal of American Society of Echocardiography and she is currently Senior Editor of Circulation. She has been very much involved at the European Society of Cardiology, in several task force of guidelines, in the Clinical Practice Guidelines Committee, European Observational Registry Programme and ESC Congress programme committee. She has been councilor of the ESC Board and is currently the President-elect of the European Association of Cardiovascular Imaging.
Pieter Doevendans
Institution:
University Hospital Utrecht, Utrecht, The Netherlands
Pieter A. Doevendans became a cardiologist in Maastricht (trained by H. Wellens) after his medical training at the Leiden University. In 1993-1994 he had the opportunity to work with Ken Chien at the University of California San Diego, where the work on embryonic stem cells started. The work was completed in Maastricht and provided the basis for a thesis on the function of the promoter of the atrial Myosin Light Chain gene. Upon return in The Netherlands he worked with Christine Mummery and Hans Clevers on both human Embryonic as well as human Cardiac stem cells. In the meantime he remained active as an interventional cardiologist initially in Maastricht, but from 2002 on in Utrecht at the UMC Utrecht. Here he was appointed full professor in Translational Cardiology in 2004 and head of the department in 2005. The focus of the department of cardiology is on Cardiac Failure, Stem Cells and Genetics. He was funded by various national and international foundations. Thus far (2017) he published more than 700 peer reviewed papers and 11 books.
Gloria Färber
Institution:
Saarland University Medical Center, Homburg/Saar, Germany
Gloria Färber started her surgical training in Freiburg (Chairman: Friedhelm Beyersdorf) and Leipzig (Chairman: Friedrich Mohr). In 20210 she promoted to Assistant Professor in the Department of Cardiothoracic Surgery at the University of Jena (Chairman: Torsten Doenst). Since January 1st 2024, Gloria Färber is Professor and the Chairman of the Department of Cardiac Surgery at the Saarland University Medical Center, Homburg/Germany. She holds board certifications in cardiac and thoracic surgery. Throughout her career, she actively pursues basic and clinical research focusing on minimally invasive surgery and heart failure. She is an active member of several editorial boards and serves as co-chair of the new EACTS/STS/AATS/Guidelines on temporary mechanical circulatory support in adults and was in the writing committee of the EACTS Expert Consensus on long-term mechanical circulatory support. Since 2018, she co-chaires the program Committee for the EACTS and DGTHG and currently for the AATS. Her clinical and surgical interests include the full spectrum of thoracic and cardiac surgery with a focus on minimally invasive surgery, valve repair, aortic surgery and heart failure surgery (incl. heart transplantation and assist device surgery).
Massimo Federici
Institution:
Policlinico Tor Vergata Hospital, Rome, Italy
Massimo Federici, MD, is Professor of Internal Medicine, Director of Center for Atherosclerosis at Policlinico Tor Vergata Hospital. After specialty in Endocrinology and Metabolic Diseases and research fellowship at Joslin Diabetes Center (Harvard Medical School), in 2000 he started an academic (clinical activity and translational research) career dedicated to investigate the molecular basis of aging-related diseases such as diabetes and atherosclerosis. Since 2002 he coordinates the Laboratory of Molecular Medicine in the Department of Systems Medicine at University of Rome Tor Vergata, funded by EU (FP7, H2020, IMI2, EU Next Generation), Italian Ministry of University, Italian Ministry of Health, Telethon, AIRC, Juvenile Diabetes Research Foundation (JDRF), European Diabetes Foundation (EFSD), Fondazione Roma and other funding agencies.
Since 2018 he is Professor and Chair in Internal Medicine at University of Rome Tor Vergata. He is co-chairman of the ESC 2023 Guidelines for the management of cardiovascular disease in patients with diabetes.
Andre Keren
Institution:
Heart Failure and Heart Muscle Disease Center, Hadassah University Hospital, Jerusalem, Israel
Andre Keren is Professor Emeritus of Medicine (Cardiology) at Hadassah-Hebrew University School of Medicine Professional Activities
1982-1984 Post Doctoral Fellow, Cardiology Division, Department of Medicine, Stanford University Hospital, Stanford, California, USA.
1993-1994 Visiting Associate Professor, Department of Medicine, Division of Cardiology, Stanford University Hospital, Stanford, California, USA. 1997-2001 Chairman of the Working Group on Myocardial and Pericardial Diseases of the Israeli Society of Cardiology
1999 – 2006 Director, Department of Cardiology, Bikur Cholim Hospital, Jerusalem, affiliated with the Hebrew University – Hadassah Medical School, Jerusalem, Israel
1999-2006 Chairman of the Jerusalem Heart Chapter of the Israel Heart Society
2001- 2004 Chairman of the National Board of Examinations in Cardiology 2006 Visiting Professor, University College of London Hospitals, London, United Kingdom
2006 – 2008 Member of the Task Force of the European Society of Cardiologyfor Guidelines of “Diagnosis and Treatment of Acute and Chronic Heart Failure 2008”.
2006- 2008 Chairman of the Working Group of Myocardial and Pericardial Diseases, of the European Society of Cardiology
2006 – 2015 Director, Heart Failure and Heart Muscle Disease Center, Hadassah-Hebrew University Hospital, Jerusalem, Israel
2014- Coordinator of National Society Meetings in the Congress Program Committee of the European Society of Cardiology
2013- Member, National Committee of Medical Accreditation of the Health Ministry 2013 – Official representative of the Israel Heart Society in the Israeli Ministry of Health Committee for revision of the regulations of athletes’ screening
2015 – Member of the National Cardiology Advisory Board of the Ministry of Health 2015- Senior Cardiologist, Hadassah-Hebrew University Hospital, Dept of Cardiology
2015 – Director of Heart Failure Services, Clalit HMO, Jerusalem District
2015 – Director of Heart Institute, Assuta Hashalom Tel Aviv, Assuta Hospitals
Fellowships: Fellow of the European Society of Cardiology, American College of Cardiology, American Heart Association Council on Cardiovascular Sciences, Israel Heart Society, International Society of Cardiovascular Ultrasound, Honorary Member of the Romanian Society of Cardiology
Publications Over 170 published papers in peer-reviewed journals
Irene Marthe Lang
Institution:
Medical University of Vienna, Austria
Professor Irene Lang is Head of Cardiac Catheterization Laboratory, Head of the Pulmonary Hypertension Outpatient Clinic at the Medical University of Vienna and Deputy Director of the Clinical Department of Cardiology.
Professor Lang’s basic and clinical research include Thrombosis and Vascular Biology, Pulmonary Hypertension and Coronary Artery Disease and ACS. Her main therapeutic areas are Stable Ischemic Heart Disease, Myocardial Infarction, Pulmonary Hypertension, Thrombosis, Vascular Biology, and Heart Failure.
Felix Mahfoud
Institution:
University Hospital Basel, Switzerland
Felix Mahfoud is professor of medicine and deputy director of the Department for Internal Medicine and Cardiology at Saarland University Hospital and Visiting Professor at Harvard-MIT, Biomedical Engineering, Boston, MA. From June 1st, Felix Mahfoud will serve as Head of Department and Professor of Cardiology at University Basel, Switzerland. Professor Mahfoud holds board certifications in internal medicine, cardiology, intensive care medicine, emergency medicine, and hypertension. He is member of several editorial boards and serves as Secretary of the Council on Hypertension of the European Society of Cardiology (ESC)‚ PCR Board of Director and program committee member (topic coordinator hypertension) of the ESC congress 2023 & 2024. He has authored more than 460 articles in peer reviewed journals and was writing committee member of the 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes, the 2018 ESC/ESH Guidelines for the management of arterial hypertension, and the 2023 ESH Guidelines for the management of arterial hypertension.
Christian Sticherling
Institution:
Department of Cardiology of the University Hospital Basel, Switzerland
Christian Sticherling is professor of Cardiology, Head of Electrophysiology and Deputy Chief of the Department of Cardiology of the University Hospital Basel, Switzerland. He received his MD from the University of Heidelberg, Germany. He completed his training in cardiology at the University of Frankfurt and the Charité University Hospital in Berlin. For his fellowship in Invasive Electrophysiology he spent 2 years at the University of Michigan in Ann Arbor, MI.
Professor Sticherling is an active member of EHRA as well as of the ESC, serves in the editorial board of Europace, is past-president of the working group “Cardiac Pacing and Electrophysiology” of the Swiss Society of Cardiology and the acting president of the Swiss Rhythmology Foundation.
He authored more than 330 peer-reviewed articles and was in the writing committee of the 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. His research interests include risk stratification of sudden cardiac death, invasive therapy of atrial fibrillation and the role of wearables for the diagnosis and monitoring of cardiac arrhythmias.
Arian Sultan
Institution:
University Heart Center Cologne, Germany
Assoc. Professor of Cardiology and Internal Medicine Arian Sultan, M.D., FEHRA, at the University Heart Center Cologne, Germany.
Med School 1997-2004 University of Hamburg, Germany, USA, Chile. Residency, Fellowship and Board Certification at University Heart Center Hamburg-Eppendorf 2004 – 2014.
In 2014 senior consultant at the University Heart Center Cologne.
Since 2022 Co-Head of the EP-Department at the University Heart Center Cologne.
2019-2021 DAS-CAM EHRA Class.
2020-2022 ESC Alumni Task Force Member.
2022-2024 EHRA SIC Committee Member.
Co-leading the women in EP initiative Germany, Swiss, Austria. Reviewer for international journals (e.g. EHJ, JACCEP, JCE, IJC), Since 2021 FEHRA (Fellow of European Society of Cardiology). Course director for the preparatory allied professional course EHRA 2022. Course director for the preparatory EHRA Exam course EHRA 202.
